HEAD JONATHAN FREDERICK 4/A
4/A · OncBioMune Pharmaceuticals, Inc · Filed Mar 14, 2019
Insider Transaction Report
Form 4/AAmended
HEAD JONATHAN FREDERICK
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-05-09+3,000,000→ 3,000,000 totalExercise: $0.01From: 2019-05-09Exp: 2028-05-09→ Common Stock (3,000,000 underlying) - Award
Employee Stock Option (right to buy)
2017-03-10+2,000,000→ 2,000,000 totalExercise: $0.25Exp: 2027-03-10→ Common Stock (2,000,000 underlying)
Footnotes (3)
- [F1]This form is being amended because the original Form 4 aggregated the two grants listed above as the same class of options, when they are actually two separate classes.
- [F2]One-third of the Stock Options vested on March 10, 2018 and March 10, 2019 and one-third will vest on March 10, 2020.
- [F3]Options issued as compensation approved by the Issuer's Board of Directors.